Raily Aesthetic Medicine International Holdings Limited (RAILY AESMED, 02135) has scheduled a board meeting for 27 March 2026. Directors will review and approve the Group’s audited financial results for the year ended 31 December 2025 and will also deliberate on a potential dividend declaration or recommendation.

The meeting notice, dated 16 March 2026 and signed by Chairman and Executive Director Mr. Fu Haishu in Hangzhou, underscores the company’s intention to release its annual figures and address shareholder returns.

As of the announcement date, the Board comprises three executive directors—Mr. Fu Haishu, Mr. Song Jianliang and Mr. Wang Ying—alongside three independent non-executive directors—Mr. Cao Dequan, Ms. Yang Xiaofen and Mr. Liu Teng.